207_Combined course Presentations

Summary

 Inhibition of EGFR in combination with RT  multiple mechanisms contribute to enhanced radiosensitivity  From DDR to Repopulation

 Secretome is as mediator of treatment resistance

 AXL is a promising target for combined radiochemotherapy

 Differential secretome analysis is a promising approach to identify predictive markers and novel targets for radiosensitization.

 Novel ADAM17 inhibitors are promising agents to improve the radiotherapy outcome of NSCLC.